Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
04/29/2011
Trade Name:
Nexium IV
Generic or Proper Name (*):
esomeprazole
Indications Studied:
Treatment of Gastroesophageal Reflux Disease (GERD) with erosive esophagitis
Therapeutic Category:
Antiulcerative
Study #:
1
Study Type:
Pharmacokinetic
Study Design:
Open Label/Traditional PK
No Patients:
59
No Centers:
10
No Countries:
4
BPCA(B), PREA(P):
P
-
-